A Study to Evaluate the Safety of ALLO-ASC-CD for Treatment of Crohn's Disease

NCT02580617 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
9
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Anterogen Co., Ltd.